Home » Procurement News - United States ImmunoGen Presents Final Data From Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination With Carboplatin and Avastin at ESMO, United states (456663697)
Procurement News
Register to View Tenders
Start Your Business Journey. Register now for 7 days Free Sample Tenders & AI Website Demo.
Start with receiving Free Data Samples related to your Products and Services
Live Tender Updates from worldwide
Access to original Tender Documents
Information on Upcoming Projects and Contract Awards